Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

June 6, 2025
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • kidney cancer

Tag: kidney cancer

  • BiotechToday
  • World

Nanoparticles to treat a common type of cancer- neuroblastoma

bioxone August 3, 2021August 2, 2021 2

Nandini Pharasi, Jaypee Institute of Information Technology What is neuroblastoma? Neuroblastoma is a condition in which malignant cells develop in the adrenal glands, neck, chest, or spinal cords neuroblasts (immature nerve tissue). A gene mutation (change) handed down from parent to kid can develop neuroblastoma. Neuroblastoma is responsible for 8–10% of all malignancies in children […]

Read More
  • BiotechToday
  • World

The recurrence of kidney cancer can be reduced

bioxone July 12, 2021July 11, 2021

Madhavi Bhatia, NIPER Guwahati Cancer is a disease that involves abnormal growth with the potential to spread to other parts of the body. There are various treatments available for cancer surgery, chemotherapy, immunotherapy, and radiotherapy. There is a higher risk of kidney cancer recurrence following surgery to remove tumours, but there is currently no treatment […]

Read More
  • BiotechToday
  • World

PARP inhibitors: One class of drugs for Multiple Forms of Cancer

bioxone June 10, 2021June 10, 2021 3

Sayak Banerjee, Amity University Kolkata Scientists have come over a class of drugs utilized in the treatment of breast and ovarian cancer which might be effective in other types of diseases with inadequate treatment alternatives. These are called PARP inhibitors which have the potential to kill cancer cells carrying a defect in the Polybromo 1(PBRM1) […]

Read More

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy